Clinical Trial Update: Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine when co-administered with routine pediatric vaccines i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Quadrivalent meningococcal conjugate vaccine (meningococcal conjugate vaccine quadrivalent (MenACWY))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Infections | Phase 3 | Status: COMPLETED | Results posted: 2025-01-22